SC
GHRS icon

Stempoint Capital’s GH Research GHRS Stock Holding History

Stempoint Capital’s Portfolio GHRS Stock Details GHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-545,275
Closed -$7.8M – 96
2025
Q3 		$7.8M Buy
545,275
+444,449
+441% +$6.22M 1.56% 18
2025
Q2 		$1.23M Buy
+100,826
New +$1.11M 0.39% 43

Other funds holding GHRS

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Stempoint Capital's GHRS Position: Q4 2025 in Review

Stempoint Capital sold out of GH Research (GHRS) in Q4 2025, closing a stake of 545,275 shares — an estimated $7.8M sold.

Stempoint Capital first reported a position in GHRS in Q2 2025 and held it in 2 quarters. The position peaked at $7.8M in Q3 2025. 53 funds tracked by Wall St. Rank hold GHRS as of Q4 2025.

  • Stempoint Capital reported no remaining GH Research position as of Q4 2025 after selling out during the quarter.
  • Stempoint Capital sold 545,275 GH Research shares in Q4 2025, an estimated $7.8M.
  • Stempoint Capital first reported a position in GH Research in Q2 2025 and held it in 2 quarters.
  • Stempoint Capital's GH Research position peaked at $7.8M in Q3 2025.
  • 53 funds tracked by Wall St. Rank held GH Research as of Q4 2025.

Based on Stempoint Capital's 13F filing for Q4 2025, filed 17 Feb 2026.